Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 6
Treatment-assignment count: 0
Stratification count: 0
Manual Review Required
MSI-H / dMMR
gastric cancer · Monoclonal Antibody
MSI-H / dMMR is flagged as manual review required because public trials show inclusion required evidence in 9 contexts. FDA CDx context exists. Threshold text varies across public records.
Threshold snippets
Fragmentation view
Threshold count: 22
Common snippets: dMMR | dMMR | MSI-H
Threshold label: Fragmented
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: Low
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT04744649 | https://clinicaltrials.gov/study/NCT05468138 | https://clinicaltrials.gov/study/NCT06099821 | https://clinicaltrials.gov/study/NCT07581574 | https://clinicaltrials.gov/study/NCT04082364 | https://clinicaltrials.gov/study/NCT06116136 | https://clinicaltrials.gov/study/NCT07127822 | https://clinicaltrials.gov/study/NCT06792162 | https://clinicaltrials.gov/study/NCT07000253